ISPOR - Cost-Utility Analysis of Eox Drug Regimen Versus Dcf Drug Regimen for the Patients with Advanced Gastric Cancer in Shiraz in 2015

Full Text

Cost-Utility Analysis of Eox Drug Regimen Versus Dcf Drug Regimen for the Patients with Advanced Gastric Cancer in Shiraz in 2015

Abstract

Authors

mJ Khezeli

Back to Volume 21, Supplemental S2

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now